0001354457-16-000297.txt : 20160217
0001354457-16-000297.hdr.sgml : 20160217
20160217092601
ACCESSION NUMBER: 0001354457-16-000297
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20160217
DATE AS OF CHANGE: 20160217
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCK CREEK PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000776008
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 521402131
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15324
BUSINESS ADDRESS:
STREET 1: 2040 WHITFIELD AVENUE
STREET 2: SUITE 300
CITY: SARASOTA
STATE: FL
ZIP: 34243
BUSINESS PHONE: 804-527-1970
MAIL ADDRESS:
STREET 1: 2040 WHITFIELD AVENUE
STREET 2: SUITE 300
CITY: SARASOTA
STATE: FL
ZIP: 34243
FORMER COMPANY:
FORMER CONFORMED NAME: STAR SCIENTIFIC INC
DATE OF NAME CHANGE: 19990122
FORMER COMPANY:
FORMER CONFORMED NAME: EYE TECHNOLOGY INC
DATE OF NAME CHANGE: 19920703
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0000776008
ROCK CREEK PHARMACEUTICALS, INC.
000-15324
4470 Cox Road
Glen Allen
VA
VIRGINIA
23060
804 530-0535
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2016-02-17
EX-99.25
2
rcpidelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
February 17, 2016, Rock Creek Pharmaceuticals, Inc.
The Nasdaq Stock Market, Inc. (the Exchange) has determined to
remove from listing the common stock of
Rock Creek Pharmaceuticals, Inc.
(the Company), effective at the opening of the trading
session on February 29, 2016. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(2). The Company was notified
of the Staffs determination on September 22, 2015. The
Company appealed the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated November 3, 2015, denying
the Company continued listing and notified the
Company that trading in the Companys
securities would be suspended on November 5, 2015.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on December 18, 2015.